sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> stem cells market

report

Stem Cells Market, By Product (Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Very Small Embryonic Like Stem Cells), By Application (Regenerative Medicine, Drug Discovery), By Technology (Cell Acquisition, Cell Production, Cryopreservation, Expansion and Sub-Culture), Therapy (Autologous Stem Cell Therapy, Allogeneic Stem Cell Therapy) – Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC320 June 2017 100+ FREE 10% CUSTOMIZATION

Stem cells are undivided biological cells which can differentiate into specialized cells (specific for a particular organ) or can divide and produce more stem cells. Although their usage is controversial up to some extent, stem cells have always been a topic of study and research for scientists worldwide. An increase in the growth of regenerative medicine has led to the growth of stem cells market. Stem cells have proved to be a solution to many of the chronic diseases. With an increase in number of chronic diseases, it is essential to understand the cellular model and provide better picture of the disease mechanism. Innovations brought to this field include infinite supply of pluripotent stem cells and mechanism for regeneration of dying cells and tissues. Research in stem cells is dominated by the approach of personalized medicine based on the disease and the health condition of the body. Studies have also been conducted to help companies carry out potential quantitative and qualitative changes in the medicines. This report studies the current and future prospects of stem cells market.

The report on the global Stem cells market uses the top-down and bottom-up approaches to define, analyze, and describe the market trends for the next five years. The report also tracks the emerging applications, innovative technologies, and mergers & acquisitions. It also focuses on the growth drivers and restraints for the key market players during the forecast period.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the market ecosystem and its impact on the revenue growth
  • Understanding of the strategies that are being adopted by the key players in this market to stay competitive
  • Valuable insights into the key technological and market trends impacting this market

KEY PREMIUM INDUSTRY INSIGHTS

  • Lower probability of contamination while sub-culturing the stem cells, advantage of high compatibility with the human body and less labor required for production are all the factors that help in boosting the stem cells market growth. The ongoing research in the field of stem cells is also favoring the growth of the market.
  • A strong need for advanced cancer therapies is boosting the growth of oncology renewing medicine which required stem cells. Rise in awareness of the recent stem cell technology is a major driving factor for the market.
  • However, there are high costs and expenses related to new stem cell therapies that are hampering the growth of the market.

The stem cells market is divided into four major geographical segments which are North America, Europe, Asia-Pacific, and the Rest of the World. The Asia-Pacific region holds the highest share of stem cells market. Due to rise in research and development projects carried out in Japan, Australia and Singapore the Asia-Pacific region is dominant. Significant investment from the government and private sector is favoring the growth of the market. North America is the emerging region as there are well-defined technologies and cellular models in the U.S. and Canada. 

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s stem cells market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the stem cells market by the following segments:

  • Stem Cells Market, by Product
    • Adult Stem Cells
    • Human Embryonic Stem Cells
    • Induced Pluripotent Stem Cells
    • Very Small Embryonic Like Stem Cells
  • Stem Cells Market, by Application
    • Regenerative Medicine
    • Drug Discovery and Development
  • Stem Cells Market, by Technology
    • Cell Acquisition
    • Cell Production
    • Cryopreservation
    • Expansion and Sub-Culture
  • Stem Cells Market, by Therapy
    • Autologous Stem Cell Therapy
    • Allogeneic Stem Cell Therapy

KEY MARKET PLAYERS

Key players in the stem cells market include:

  • Advanced Cell Technology Inc.
  • STEMCELL Technologies Inc.
  • BIOTIME, INC.
  • CellGenix GmbH
  • PromoCell GmbH
  • Kite Pharma
  • Cellartis AB
  • Angel Biotechnology
  • BrainStorm Cell Therapeutics
  • Celgene Corporation

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

TRENDING RELATED REPORT

Stem Cell Therapy Market, by Treatments (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), Applications (Oncology, Eye Diseases, Central Nervous System Diseases, Musculoskeletal Diseases, Wound & Injuries, Metabolic Disorders, Cardiovascular Disorders, Immune System Disorders), End-users (Hospitals, Ambulatory Surgical Centers) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Technology Roadmap
  5. STEM CELLS MARKET, BY PRODUCT
    1. Segment Share
    2. By Product
      1. Adult Stem Cells
      2. Human Embryonic Stem Cells
      3. Induced Pluripotent Stem Cells
      4. Very Small Embryonic Like Stem Cells
  6. STEM CELLS MARKET, BY APPLICATION
    1. Segment Share
    2. By Application
      1. Regenerative Medicine
      2. Drug Discovery and Development
  7. STEM CELLS MARKET, BY TECHNOLOGY
    1. Segment Share
    2. By Technology
      1. Cell Acquisition
      2. Cell Production
      3. Cryopreservation
      4. Expansion and Sub-Culture
  8. STEM CELLS MARKET, BY THERAPY
    1. Segment Share
    2. By Therapy
      1. Autologous Stem Cell Therapy
      2. Allogeneic Stem Cell Therapy
  9. STEM CELLS MARKET, BY GEOGRAPHY
    1. Segment Share
    2. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Product
      3. By Application
      4. By Technology
      5. By Therapy
    3. Europe
      1. By Regions
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Product
      3. By Application
      4. By Technology
      5. By Therapy
    4. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Product
      3. By Application
      4. By Technology
      5. By Therapy
    5. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East & Africa
      2. By Product
      3. By Application
      4. By Technology
      5. By Therapy
  10. COMPETITIVE LANDSCAPE
    1. Market Positioning of Key Players, 2016
    2. Key Innovators
  11. KEY MARKET PLAYERS 
    1. Advanced Cell Technology Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    2. STEMCELL Technologies Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    3. BIOTIME, INC.
      1. Overview
      2. Key Strategies
      3. Key Developments
    4. CellGenix GmbH
      1. Overview
      2. Key Strategies
      3. Key Developments
    5. PromoCell GmbH
      1. Overview
      2. Key Strategies
      3. Key Developments
    6. Kite Pharma
      1. Overview
      2. Key Strategies
      3. Key Developments
    7. Cellartis AB
      1. Overview
      2. Key Strategies
      3. Key Developments
    8. Angel Biotechnology
      1. Overview
      2. Key Strategies
      3. Key Developments
    9. BrainStorm Cell Therapeutics
      1. Overview
      2. Key Strategies
      3. Key Developments
    10. Celgene Corporation
      1. Overview
      2. Key Strategies
      3. Key Developments
  12. SCALAR 360 DEGREE MARKET PERSPECTIVE
  13. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us